Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comprehensive Evaluation of MRI-AI in Prostate Cancer Diagnosis: a Real-World Prospective Diagnostic Study

NCT06575361 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT06575361
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06575361 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comprehensive Evaluation of MRI-AI in Prostate Cancer Diagnosis: a Real-World Prospective Diagnostic Study
Lead sponsor
Peking University First Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2024
Completion date
August 31, 2025
Enrollment
365 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer